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ABSTRACT Intramolecular interactions between the amino and carboxy termini of apolipoprotein A-I (apoAI) are believed to
stabilize the helix bundle conformation of the protein. During lipid assembly the protein undergoes conformational changes that
result in an exposure of the carboxy terminus and its insertion into the lipid phase. To determine the role of the two termini in the
energetics of unfolding, we studied the guanidine-hydrochloride-induced unfolding and refolding of apoAI as well as its
N-terminal deletion (del[1–43]), C-terminal deletion (del[186–243]), and the double deletion containing only the central residues
44–185. Thermodynamic analysis of the equilibrium unfolding measured by ﬂuorescence spectroscopy revealed the presence
of an intermediate unfolded state (Iequil) in addition to the native (N) and unfolded states. Refolding kinetics of apoAI, measured
by stopped-ﬂow circular dichroism, revealed two kinetic intermediates, Iburst and Irecovery. Computer modeling suggested that the
ﬁrst resembles the partially unfolded protein, whereas the second overlaps with the native state of the protein. The free energy
changes for the N/ Iequil transition of the N-terminal and double deletions were lower then that of the full-length form, whereas
that for the C-terminal deletion was higher. Our ﬁndings suggest that the N-terminus of apoAI stabilizes the native state of the
protein by increasing the Eyring energy barrier for the N/ Iequil unfolding transition; whereas the carboxyl terminus destabilizes
that state.
INTRODUCTION
The 243-amino-acid apolipoprotein A-I (apoAI) is the main
protein component in high-density lipoprotein (HDL) and
thus plays an important role in reverse cholesterol transport
and reduction in risk for cardiovascular and atherosclerotic
diseases (1). HDL is the main mediator of the ‘‘reverse cho-
lesterol transport’’ pathway by acting as an acceptor of cel-
lular cholesterol and transporting this cholesterol to the liver
where it can be excreted directly or indirectly after conver-
sion to bile acids (2). Lipid-free apoAI can also act as an
acceptor of cellular cholesterol in a process that is mediated
by the membrane protein ABCA1 (3,4). The primary se-
quence of apoAI from residues 44–243 can be divided into
22- and 11-residue tandem repeats that form type A am-
phipathic a-helices (5). Although the crystal structure of the
entire lipid-free apoAI has not been determined, the
C-terminal a-helices appear to have a less organized struc-
ture than the rest of the protein (6,7). Secondary-structure pre-
dictions suggest that the amino-terminal 43 amino acids form
a G* class amphipathic a-helix (8). Deletion of these 43
amino acids (N-terminal deletion, or del[1–43]) allowed crys-
tals of the lipid-free protein to be obtained, and the x-ray
structure of this protein has been used as a model for the
conformation that resembles the one conferred on the intact
protein upon binding to lipid in its lipid-bound state (6). This
result is consistent with the ﬁnding by Borhani et al. (6), who
reported, using x-ray crystallography, that the del[1–43]
mutant of apoAI forms an extended a-helix horseshoe-
shaped belt, with the N- and C-termini at adjacent ends of
this horseshoe, and a tetramer of these stacked in an offset
antiparallel manner to a size consistent with apoAI lipid disks.
This view is also supported by the ﬁnding that in recombi-
nant discoidal HDL, apoAI forms an extended series of
a-helices that circumscribe the perimeter of the disk-shaped
phospholipid bilayer such that the a-helix segments align
perpendicular to the fatty acid chains of the phospholipids
(9–11). The amino-terminal deletion has lipid binding and
ABCA1-dependent cholesterol acceptor activity equivalent
to that of full-length apoAI (12,13). 1-Anilinonaphthalene-8-
sulfonate binding experiments and circular dichroism spec-
troscopy have demonstrated that an extended portion of the
amino terminus (amino acids 1–90) is critical for maintaining
and stabilizing the folded, lipid-free structure of apoAI (14).
In contrast, carboxy terminal deletions ([1–192]apoA1) ex-
hibit severely impaired lower lipid binding and ABCA1-
dependent cholesterol acceptor activity (13,15). Interestingly,
double deletion of both the N- and C-termini of apoAI leads
to a restoration of these apoAI activities, showing that the
central domain is sufﬁcient for these functions of apoAI
(13,15).
Davidson and colleagues have recently proposed a detailed
folded helical bundle model of the lipid-free form of apoAI,
with the hydrophobic faces binding adjacent surface and the
N- and C-termini in close proximity with each other (11,16).
Lipid binding is thought to ﬁrst occur in the C-terminus,
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which undergoes a transition from an unordered to an
a-helical conformation and acts as the trigger to allow expo-
sure of the remainder of apoAI hydrophobic domains to the
lipid phase (7). The idea that the carboxy terminus of the pro-
tein is associated with or embedded within the lipid phase
is further supported by the ﬁnding that, when bound to lipid,
the carboxy terminus of human apoAI was less susceptible
to proteolytic cleavage than the amino terminus (17,18). An
earlier study indicated that lipid binding of apoAI proceeds
via a molten globule (MG) state (19). The MG state is a
partially folded, nonnative-state conformation of the protein
that plays a key role in a variety of physiological functions
such as lipid-binding or penetration of the protein into the
lipid bilayer in a variety of globular proteins (20). The MG
state appears to be intermediate between the native and dena-
tured states, is relatively compact, and is characterized by a
well-preserved secondary structure and a signiﬁcant reduction
in tertiary structure (21,22).
In this study, we used circular dichroism (CD) spectros-
copy in combination with stopped-ﬂow techniques to dem-
onstrate that lipid-free apoAI forms at least two kinetic
folding intermediate states (Iburst and Irecovery). In another set
of experiments, using ﬂuorescence spectroscopy under equi-
librium conditions, we also found a denatured state of the
protein that is stable in 3 M GdnHCl. This unfolded inter-
mediate state, which we refer to as an equilibrium interme-
diate state (Iequil), has a CD spectrum that closely resembles
the denatured state of the protein and a ﬂuorescence spec-
trum that is distinct from either that of the native protein state
(N, observed at 0 M GdnHCl) or the unfolded state (U,
observed at 5 M GdnHCl). Deletion of the amino terminus of
the protein stabilizes Iequil by lowering the Eyring energy
barrier for the N/ Iequil transition. Deletion of the carboxy
terminus, on the other hand, stabilizes the N state of the
protein by elevating that barrier. These ﬁndings have impli-
cations for lipid binding.
MATERIALS AND METHODS
ApoA1 mutant constructs
cDNA encoding 6-his-tagged recombinant human apoAI (rh-apoAI) in the
pET-20b bacterial expression vector was a gift from Dr. Michael Oda (23).
Deletions and stop codon point mutations were made by polymerase chain
reaction and use of the Quick-change Mutagenesis Kit (Stratagene, La Jolla,
CA) to create del[1–43], the C-terminal deletion (del[186–243]), and the
N- and C-terminal double deletion, containing only the central residues 44–
185. All mutations were conﬁrmed by DNA sequencing. The plasmids were
transformed into Escherichia coli strain BL21(DE-3) pLysS, and apoAI
expression was induced with 0.5 mM isopropyl-b-D-thiogalactopyranoside
by overnight incubation at room temperature. The cell pellet was dissolved
in B-PER lysis buffer (BioRad, Hercules, CA) followed by centrifugation to
sediment cell debris. The supernatant was diluted into phosphate-buffered
saline containing 3 M GdnHCl, pH 7.0, and then loaded onto a nickel-
chelating histidine-binding resin column and speciﬁcally eluted with im-
idazole as previously described (23). Recombinant apoAI was dialyzed
extensively in 100 mM sodium phosphate buffer, pH 7.0, containing 100
mM DTPA. ApoAI samples were analyzed by electrophoresis on a 14%
sodium dodecyl sulfate polyacrylamide gel under reducing conditions. The
gels were stained for protein with 0.25% Coomassie blue. All samples were
.95% pure by this method (data not shown). All constructs in this study
contained the same amino-terminal 6-his tag. Pilot studies with puriﬁed
native human apoAI revealed CD and ﬂuorescence spectra as well as folding
kinetics that were very similar to the 6-his-tagged recombinant human apoAI
used in this study (data not shown).
Equilibrium spectra
Steady-state ﬂuorescence spectra were measured with a Perkin-Elmer
(Wellesley, MA) LS-50B spectroﬂuoremeter. Samples of 25 mg/ml apoAI
were prepared in PBS (10 mM phosphate buffer, pH 7.4, 150 mM NaCl)
and the indicated concentration of GdnHCl. Steady-state CD spectra were
acquired with an Applied Photophysics (Leatherhead, Surrey, UK) piStar180
spectrophotometer equipped with a thermostated equilibrium sample han-
dling unit.
Free energy of GdnHCl-induced unfolding (DGNU) was calculated by
three independent methods as follows:
Method I
By ﬁtting the equilibrium CD data (see Fig. 2 b) to the relationship DGNU ¼
RTlnKD, where the equilibrium constant KD is calculated from the mean
residual ellipticity (MRE) using the relation:
KD ¼ ð½uN  ½uÞ=ð½u  ½uDÞ; (1)
where [u] is the observed MRE at a given concentration of GdnHCl and [u]N
and [u]D are theMREs for the native and fully denatured forms of the protein.
Method II
By ﬁtting the equilibrium wavelength of maximum ﬂuorescence (WMF)
data (see Fig. 3 b) to the relationship DGNU ¼ RTlnKD, where the equi-
librium constant KD is calculated from the WMF (peak ﬂuorescence
emission for 295-nm excitation) using the relation
KD ¼ ðWMFN WMFÞ=ðWMFWMFDÞ; (2)
where WMF is the observed WMF at a given concentration of GdnHCl and
WMFN andWMFD are the WMFs for the native and fully denatured forms of
the protein.
Method III
By ﬁtting Eq. 13 (see Results section) to the ﬂuorescence peak intensity data
(as depicted in Fig. 3 c).
Kinetics of refolding/unfolding
All fast kinetics studies were carried out with an Applied Photophysics
piStar180 spectrophotometer equipped with an xv18 stopped-ﬂow mixing
chamber. The observed kinetic curves were ﬁtted by the nonlinear least-
squares method with the multiexponential relation:
AðtÞ ¼ Ao1SiAiexpðkitÞ; (3)
where A(t) and Ao are the signal values at time t and at inﬁnite time,
respectively; and Ai and ki are the amplitude and the rate constant of phase i.
Computer modeling
Free energy changes, m values, and the molar fractions of the three protein
folding states—native, unfolded, and intermediate—were calculated by
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globally ﬁtting all equilibrium peak ﬂuorescence data (see Fig. 3 c) to Eq. 13
(see Results section) using the SCoP modeling package (24,25).
Reagents
Ultrapure GdnHCl was from USB Chemicals (Cleveland, OH). All other
salts were from Sigma-Aldrich (St. Louis, MO).
RESULTS
In the ﬁrst set of experiments, we used CD to measure the
kinetics of the change in MRE at 222 nm ([u]222) upon re-
folding of apoAI initiated by a GdnHCl concentration jump
from 5 M to 0.45M using a stopped-ﬂow apparatus. Fig. 1 a
illustrates the outcome of such an experiment performed with
full-length apoAI. As can be seen, [u]222 rapidly decreases
(a-helix content increases) with an overshoot before relaxing
toward the value characteristic of the native protein. We thus
labeled the fast, or burst, phase intermediate Iburst, and the
recovery phase intermediate Irecovery. The kinetics of signal
recovery upon refolding as shown in Fig. 1 a was best ﬁtted
by a double exponential function (see Table 1). Table 1 also
lists the corresponding values for the three deleted forms
of apoAI. Comparing the rate constants for the N/ Iburst
transition of protein refolding in Table 1 reveals the fol-
lowing order of folding kinetics (starting from the fastest):
del[186–243] . apoAI ; apoAI[44–185] . del[1–43].
Accordingly, the Eyring free energy barrier for the Iburst/
N transition is largest for the del[1–43] mutant and smallest
for the del[186–243] mutant. We also studied the unfolding
of apoAI and its deleted forms. This was done by measuring
u222 immediately after a GdnHCl concentration jump from 0
to 4.55M. In contrast to the refolding experiments, the kinetic
traces of the unfolding process for all four proteins could be
ﬁtted with a single exponential function (Table 1). Furthermore,
the kinetic traces did not exhibit an overshoot (Fig. 1 b).
The overshoot in the CD signal at 222 nm observed in the
refolding experiments suggests the presence of a folding
intermediate. To gain more insight into the properties of this
intermediate and whether it can also be obtained at equi-
librium, we performed a series of measurements under equi-
librium conditions. At equilibrium, the secondary structure
of apoAI is rich in a-helix. Fig. 2 a depicts the far-ultraviolet
(UV) CD spectra of native apoAI with a large negative ellip-
ticity between 210 and 230 nm indicative of the presence of
a-helix. Most of the a-helix structure is lost in the unfolded
state achieved in 5 M GdnHCl. The dose-dependent loss of
molar ellipticity at 222 nm ([u222]), indicative of a-helix con-
tent, with increasing GdnHCl concentration is shown in Fig.
2 b, along with the corresponding EC50 values, for full-length
apoAI as well as for the N-terminal, C-terminal, and double
N- and C-terminal deleted forms. The smaller EC50 of del[1–
43] compared to the other three mutants suggests a lower
energy barrier for the unfolding transition of the N-terminal
deleted mutant. This is consistent with a role for the amino
terminal in stabilizing the folded, N, state of the protein.
The ﬂuorescence emission spectra of apoAI is shown in
Fig. 3 a. In the absence of denaturant the spectrum exhibits a
peak at around 340 nm. At 5 M GdnHCl, the emission peak
shifts to the red. This shift in the WMF of full-length apoAI
as well as of the three deleted forms, with increasing GdnHCl
concentration is shown in Fig. 3 b along with the corre-
sponding EC50 values. Comparing the EC50 values of all four
mutants, the amino-terminal deletion exhibits the smallest
value of all four with EC50 of 0.88 M. This is consistent with
a lower energy barrier of the unfolding transition for the
amino-terminal deletion as compared to the other mutants
and further supports the notion that this segment of the pep-
tide stabilizes the folded native state of the protein. It should
FIGURE 1 (a) Kinetic refolding curves for full-length apoAI measured by
far-UV CD at 222 nm and converted to MRE units. Refolding reaction was
initiated by a GdnHCl concentration jump from 5 M to 0.45 M. The
experimental data (dots) were ﬁtted with Eq. 3 (solid line). The inset shows
the difference between the theoretical curve and the experimental data. The
single data point represented by a solid square at the top left corner of the
graph is the MRE value at 222 nm of the native protein. (b) Kinetic
unfolding curves for full-length apoAI measured by far-UV CD at 222 nm
and converted to MRE units. Unfolding reaction was initiated by a GdnHCl
concentration jump from 0 M to 4.55 M. The experimental data (dots) were
ﬁtted with Eq. 3 (solid line). The inset shows the difference between the
theoretical curve and the experimental data. The single data point repre-
sented by a solid triangle at the bottom left corner of the graph is the MRE
value at 222 nm of the unfolded protein.
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also be noted that the EC50 values for the WMF changes are
slightly larger then the EC50 values observed for the ellip-
ticity changes as a function of GdnHCl concentration. This
result suggests that conformational changes to the secondary
structure of the protein precede changes in the tertiary
structure. Fig. 3 c shows the ﬂuorescence emission intensity
of these apoAI forms at the peak of their respective spectra. It
should be noticed that apoAI has four Trp residues, whereas
the other three constructs have only three Trp residues each,
and that it therefore would have a lower ﬂuorescence quan-
tum yield. To account for this difference in ﬂuorescence
quantum yield we normalized, for each of the four constructs,
the peak ﬂuorescence intensity at each GdnHCl concentration
to the intensity at zero GdnHCl. Interestingly, all four forms
of apoAI exhibit a biphasic proﬁle with a decreasing nor-
malized peak ﬂuorescence intensity between 0 and ;2 M
GdnHCl that then increases between ;3 and 5 M GdnHCl
(Fig. 3 c). These biphasic behaviors cannot be described by a
simple two-state unfolding transition, but can be ﬁtted with a
three-state transition scheme as described by Eq. 4 below.
This scheme suggests the presence of a folding intermediate
that exists in the transition range of GdnHCl concentration.
To gain more insight into the thermodynamics of the
equilibrium intermediate state, depicted in Fig. 3 c as a nadir
in the peak ﬂuorescence curves, we used a mathematical
model that describes the folding processes of apoAI as an
equilibrium transition reaction between the native and un-
folded states and an intermediate state (26–29). In this
model we propose a three-state folding scheme as described
below.
U4Iequil4N; (4)
where N and U are the native and unfolded states and Iequil
is the equilibrium unfolding intermediate. The equilibrium
constant between N and I is given by
KNI ¼ fIðgÞ=fNðgÞ: (5)
Similarly, the equilibrium constant between N and U is given
by
KNU ¼ fUðgÞ=fNðgÞ; (6)
where fN(g), fI(g) and fU(g) are the fractions of the three states
at a denaturant (GdnHCl) concentration of g ( fN1 fI1 fU¼ 1).
The measured ﬂuorescence intensity of the protein at a
given wavelength is a superposition of the contribution from
all three states:
TABLE 1 Rate constants (s1) for refolding and unfolding kinetics of apoAI
[GdnHCl]*ﬁnal apoAI del[1–43] apoAI del[186–243] apoAI [44–185] apoAI
Refold
Unfold
Refold
Unfold
Refold
Unfold
Refold
Unfold
Refold/
unfold
Fast
phase
Recovery
phase
Fast
phase
Recovery
phase
Fast
phase
Recovery
phase
Fast
phase
Recovery
phase
0.45/1.2 3.01 6 0.3 0.59 6 0.05 0.22 6 0.02 1.21 6 0.1 0.41 6 0.04 0.48 6 0.04 4.82 6 0.4 0.47 6 0.04 0.13 6 0.01 2.31 6 0.2 0.49 6 0.04 0.32 6 0.03
0.60/1.6 2.86 6 0.2 0.46 6 0.04 0.26 6 0.02 1.14 6 0.1 0.35 6 0.03 0.59 6 0.05 4.51 6 0.4 0.38 6 0.04 0.15 6 0.01 2.26 6 0.2 0.38 6 0.04 0.41 6 0.04
0.70/2.0 2.72 6 0.2 0.38 6 0.03 0.37 6 0.03 0.98 6 0.1 0.28 6 0.02 0.68 6 0.05 4.13 6 0.4 0.31 6 0.03 0.18 6 0.02 2.11 6 0.2 0.31 6 0.03 0.53 6 0.05
0.80/2.5 2.12 6 0.2 0.28 6 0.02 0.50 6 0.04 0.69 6 0.06 0.21 6 0.02 0.76 6 0.07 3.27 6 0.3 0.22 6 0.02 0.21 6 0.02 1.51 6 0.1 0.21 6 0.02 0.65 6 0.06
1.00/3.0 1.02 6 0.1 0.23 6 0.02 0.67 6 0.05 0.38 6 0.03 0.15 6 0.01 0.85 6 0.08 3.02 6 0.3 0.15 6 0.01 0.25 6 0.02 0.65 6 0.06 0.13 6 0.01 0.78 6 0.07
*The refolding reaction initiated by a GdnHCl concentration jump from 5 M to the ﬁnal value is indicated to the left of the slash (/), and the unfolding
reaction initiated by a GdnHCl concentration jump from 0 M to the ﬁnal value is indicated to the right of the slash.
FIGURE 2 (a) CD spectra of full-length apoAI in the far-UV region.
Shown are spectra of the protein in the native (N, solid line, 0 M GdnHCl),
unfolded (U, dotted line, 5 M GdnHCl), and intermediate (I, dashed line)
forms calculated with Eq. 15, as explained in the text. Open squares
represent the CD spectrum of the burst phase intermediate and the solid
squares represent the spectrum of the recovery phase intermediate, as
explained in the text. (b) MRE at 222 nm as a function of concentration
of GdnHCl, measured at equilibrium, for the following forms of apoAI
(corresponding EC50 values are also indicated): full-length (squares, 1.17
M), del[1–43] (triangles, 0.77 M), del [186–243] (circles, 1.19 M), and [44–
185] (diamonds, 1.11 M).
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BobsðgÞ ¼ BN fNðgÞ1BI fIðgÞ1BU fUðgÞ; (7)
where Bi represents the ﬂuorescence intensity of the ith state.
The concentration of each state is related to the equilibrium
constants by the following relations (28,29):
fN ¼ 1
11KNI1KNU
¼ 1
11 eDGNI=RT1 eDGNU=RT
(8)
fI ¼ KNI
11KNI1KNU
¼ e
DGNI=RT
11 eDGNI=RT1 eDGNU=RT
(9)
fU ¼ KNU
11KNI1KNU
¼ e
DGNU=RT
11 eDGNI=RT1 eDGNU=RT
; (10)
where DGNI and DGNU are the free energy changes for the
transition from the N to the Iequil state and from the N to the U
state, respectively, and R and T have their usual meanings.
We further assume that the free energy of unfolding varies
linearly with g, so that
DGNI ¼ DGwaterNI  mNIg (11)
DGNU ¼ DGwaterNU  mNUg; (12)
where DGwaterNI and DG
water
NU are the free energy changes,DGNI
and DGNU, at 0 M GdnHCl, respectively. mNI and mNU are
the cooperativity indexes of the transitions. Combining
Eqs. 4–12 and assuming the coefﬁcients Bi are linearly depen-
dent on g, we get (28)
BobsðgÞ ¼ BN1BIe
fðDGWaterNI mNIgÞ=RTg1BUe
fðDGWaterNU mNUgÞ=RTg
11 efðDG
Water
NI mNIgÞ=RTg1 efðDG
Water
NU mNUgÞ=RTg
:
(13)
The data in Fig. 3 c were analyzed with Eq. 13 using
global analysis and were ﬁtted simultaneously. The results
are shown in Table 2. Examination of the data depicted in
Table 2 reveals that del[186–243] exhibits the largest free
energy change for the N/ U transition with 5.03 kcal/mol
followed by full length apoAI (4.50 kcal/mol); apoAI
[44–185] (3.47 kcal/mol), and del[1–43] (2.4 kcal/mol).
Chevron plots
To further evaluate the kinetic scheme of folding of apoAI
and its deleted forms, we carried out a series of GdnHCl
concentration jump experiments using the stopped-ﬂow
system. In these experiments, we monitored the kinetics of
the protein’s CD signal change at 222 nm after concentration
jumps from high to various ﬁnal low concentrations of
GdnHCl. In addition, details of the unfolding kinetics were
acquired after concentration jumps from 0 M to ﬁnal con-
centrations in the range of 1–4 M GdnHCl. The kinetic
curves from the unfolding experiments were ﬁtted to a single
exponential from which the rate constants for the unfolding
kinetics were calculated. The refolding kinetic traces were
ﬁtted to a two-exponential function from which the rate con-
stants for the fast and recovery kinetic phases were cal-
culated. The logarithm of the rate constants (lnKobs) for the
fast refolding phase measured at 222 nm were plotted as a
function of the ﬁnal GdnHCl concentration in the mixing
chamber (Fig. 4). On the same graph we also plotted the
logarithm of the rate constants for the unfolding kinetic
FIGURE 3 (a) Fluorescence spectra of full-length apoAI at 0 and 5 M
GdnHCl, as indicated on the graphs. lexc ¼ 295 nm. (b) WMF and EC50
values as a function of GdnHCl concentration measured at equilibrium for
full-length apoAI (squares, 1.38 M), del[1–43] (triangles, 0.88M), del[186–
243] (circles, 1.51 M), and [44-185] apoAI (diamonds, 1.29 M). lexc ¼
295 nm. (c) Fluorescence intensity at the peak of emission spectrum as a
function of GdnHCl concentration measured at equilibrium for full-length
apoAI (squares), del[1–43] apoAI (triangles), del[186–243] apoAI (circles),
and [44–185] apoAI (diamonds). Symbols represent the experimental data
and lines represent the theoretical curves predicted by Eq. 13. lexc¼ 295 nm.
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traces. Such plots are referred to as ‘‘chevron plots’’ (30–32).
The unfolding branch of the chevron plots did not show any
detectable curvature. On the other hand, nonlinearities were
observed for the refolding part of the plots (,0.5MGdnHCl).
This curvature could be due to the presence of an early
folding intermediate that forms during the dead time of the
instrument and becomes increasingly populated under sta-
bilizing conditions (i.e., at low GdnHCl concentration).
CD spectra of the I state
To gain more insight into the spectral properties of the
intermediate states of apoAI, we tried to reconstruct the CD
spectra of these states. To achieve this task we used two
approaches. 1), In the ﬁrst approach, we measured the kinet-
ics of apoAI refolding using stopped-ﬂow techniques at
different wavelengths after a decrease in GdnHCl concen-
tration from 5 to 0.45 M as depicted in Fig. 1 a. The spectrum
of the intermediate was reconstructed by extrapolating the
CD signal, measured at each wavelength, to time zero. The
spectrum obtained by this method represents the burst phase
intermediate (Iburst) and is shown in Fig. 2 a (open squares).
2), In the second approach, we calculated the CD spectra of
the intermediate state, as described below. The observed
molar ellipticity, [u]obs, at each wavelength is a superposition
of the molar ellipticities of the N, I, and U states (28), i.e.,
½u
obs
ðlÞ ¼ fN½uNðlÞ1 fI½uIðlÞ1 fU½uUðlÞ; (14)
where fI represents the molar fraction of the j state. fj was
calculated using Eqs. 8–10. The CD spectrum of the I state is
thus given by
uIðlÞ ¼ uobsðlÞ  uNðlÞfN  uUðlÞfU
fI
; (15)
where uN(l) and uU(l) are the experimentally measured
ellipticities of apoAI at 0 and 5M GdnHCl, respectively. The
CD spectrum obtained this way for full-length apoA1 is
shown in Fig. 2 a (theory). As can be seen, the spectrum of
Itheory is very close to the spectrum of Iburst, suggesting that
the latter represents a bona ﬁde intermediate state.
Kinetic difference spectra
The exponential ﬁt of the refolding kinetics curves measured
at 10 different wavelengths provides kinetic difference CD
spectra for the I/ N transition phase (28). The difference
spectra are related to fractional changes in secondary and/or
tertiary structure components, which occur during the differ-
ent kinetic phases. The difference spectra for this transition
are given by the wavelength dependence of the amplitudes of
the fast and recovery exponential functions (see Fig. 1 a). In
Fig. 5, we show the kinetic difference spectra calculated
from the exponential ﬁts of the refolding curves measured at
10 different wavelengths. The spectra are for the I / N
transition of apoAI.
DISCUSSION
Protein folding is a fundamental process in biology that is not
yet fully understood. Nevertheless, it has been generally
accepted that detection and characterization of intermediate
conformational states between the native and fully unfolded
states are useful for elucidating the mechanism of folding of
globular proteins.
TABLE 2 Thermodynamic parameters for equilibrium unfolding of apoAI mutants
Wild-type apoAI del[1–43] apoAI del[186–243] apoAI [44–185] apoAI
Parameter I II III I II III I II III I II III
DGwaterNI ðkcal=molÞ 2.4 6 0.2 1.6 6 0.1 3.5 6 0.3 1.8 6 0.1
DGwaterIU ðkcal=molÞ 1.9 6 0.2 1.0 6 0.1 1.8 6 0.1 2.0 6 0.2
DGwaterNU 4.5 6 0.4 4.7 6 0.4 4.3 6 0.4 2.4 6 0.2 2.2 6 0.2 2.6 6 0.2 5.1 6 0.4 4.7 6 0.4 5.3 6 0.4 3.2 6 0.3 3.4 6 0.3 3.8 6 0.3
mNI (kcal/mol) 2.1 6 0.2 1.2 6 0.1 3.1 6 0.3 1.9 6 0.2
mIU (kcal/mol) 1.4 6 0.1 0.8 6 0.1 2.1 6 0.2 1.2 6 0.1
mNU (kcal/mol) 3.6 6 0.3 3.9 6 0.3 3.5 6 0.3 1.9 6 0.2 1.8 6 0.2 2.0 6 0.2 5.1 6 0.5 4.7 6 0.5 5.2 6 0.5 2.8 6 0.2 2.6 6 0.2 3.1 6 0.3
I, II, and III refer to the three different methods used to calculate the change in free energy of the indicated transition; m is the GdnHCl susceptibility
parameter and is given in Eqs. 11 and 12.
FIGURE 4 Chevron plots showing GdnHCl concentration dependence of
the observed rate constants for the refolding and unfolding reactions of
apoAI measured by CD at 222 nm: full-length apoAI (squares); del[1–43]
apoAI (triangles); del[186–243] apoAI (circles); and [44–185] apoAI
(diamonds).
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In the past, apoAI unfolding transitions were studied by
steady-state CD spectroscopy and spectral shifts in the wave-
length of maximum ﬂuorescence (33). Unfortunately, equi-
librium CD spectra and the WMF cannot capture short-lived
intermediate states of the protein. The CD spectrum reﬂects
changes in the secondary structure (i.e., a-helix), whereas the
WMF reﬂects only the dielectric constant (electrical polarity)
of the ﬂuorophore microenvironment. Indeed, in our hand,
the ellipticity parameter has already reached and completed
its full range of change within several hundred milliseconds.
The ﬂuorescence intensity (which is proportional to the ﬂuo-
rescence quantum yield and thus the transition dipole mo-
ment) is a more complicated function that also includes large
geometrical coefﬁcients and short distances between Trp
residues and other groups that can act as ﬂuorescence quench-
ers. These parameters reﬂect the tertiary, as opposed to the
secondary, structure of the protein. The secondary structure
goes through a two-state transition upon folding (as illus-
trated in Figs. 2 b and 3 b), whereas the tertiary structure does
not (Fig. 3 c).
The data obtained in our refolding kinetics experiments
(Fig. 1 a) suggest that there are at least two intermediate
states of apoAI, the burst phase intermediate (Iburst) and the
slower intermediate formed by the recovery phase (Irecovery).
The intermediate formed by the ﬁrst phase exhibits an
overshoot in the time-dependent ellipticity change at 222
nm. To determine whether the formation of the nonnative
a-helix, represented by the overshoot in the CD ellipticity, is
crucial for directing the subsequent folding process, one has
to establish the kinetic role of the burst phase intermediate. If
the intermediate is an on-pathway and obligatory one, there
should be a lag period in the appearance of the N state. We
could not observe a lag phase, however, because the forma-
tion of the burst phase is too fast to be measured by our
stopped-ﬂow apparatus. Alternatively, the overshoot may
represent a parallel, rather than a sequential, reorganization
(e.g., due to cis-trans isomerization of X-pro peptide bonds)
of the secondary structure within the already compact state
formed in the burst phase.
The kinetic CD spectra represent the time-dependent
changes in the structure of apoAI during the refolding pro-
cess. The difference spectrum from I to N exhibits both pos-
itive and negative bands with an isoellipticity point at 222 nm.
This pattern is characteristic of an exciton coupling effect
The presence of an exciton in the kinetic difference spectrum
suggests a close proximity between at least two Trp residues
during the folding process (34,35).
Previous studies have shown that deletion of the carboxyl
terminus of apoAI results in impaired lipid binding by the
protein (36). Our data on GdnHCl-induced equilibrium un-
folding states suggest that the N/U free energy change
(DGwaterNU ) of the del[186–243] mutant is comparable to that of
full-length apoAI (5.0 6 0.4 vs. 4.5 6 0.2 kcal/mol). This
ﬁnding would argue against the view that lipid binding is
associated with a complete unfolding of the protein. How-
ever, a closer examination of the free energy change data
shown in Table 2 reveals that the N/I transition DGwaterNI for
del[186–243] is signiﬁcantly larger than that for full-length
apoAI (3.46 0.3 vs. 2.56 0.2 kcal/mol). This ﬁnding would
be consistent with the idea that the intermediate state of
apoAI faclilitates lipid binding by lowering the free energy
barrier for the binding of the native state of apoAI to lipid
(Fig. 6). Further support for the notion that the intermediate
state may play a role in lipid binding emerges from our ﬁnd-
ing that DGwaterNI for the del[1–43] mutant is signiﬁcantly
smaller than that for full-length apoAI (1.5 6 0.1 vs. 2.5 6
0.2 kcal/mol; see Table 2). This ﬁnding is consistent with the
FIGURE 5 Kinetic difference spectrum of the refolding of full-length
apoAI from I to N. Data were calculated from kinetic CD spectra acquired at
10 different wavelengths, as indicated, during refolding experiments of
apoAI upon GdnHCl concentration jumps from 5 M to 0.45 M. The spectra
were calculated as the difference in the preexponential amplitudes of the
recovery phase and the slow decay phase as illustrated in Fig. 1 A.
FIGURE 6 Gibbs free energy diagram for the different states of apoAI.
The free energy changes given in Table 2 for transitions between the
different states of the protein are also indicated. A putative transition
between the intermediate state (I) and lipid bound protein (L) is also depicted
in the diagram. The existence of a folding intermediate state would lower the
free energy barrier for lipid binding of apoAI.
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previous ﬁnding that removal of the ﬁrst 43 amino acids of
apoAI allows the protein to be crystallized in a conformation
that is thought to resemble the lipid-bound form of the intact
protein. Our hypothesis regarding the role of the I state of
apoAI in lipid binding further predicts that the [44–185] mu-
tant would bind lipid somewhat more strongly than full-length
apoAI, as the former exhibits a slightly lower DGwaterNI (2.06
0.1 vs. 2.56 0.2 kcal/mol; see Table 2). Further studies will
be needed to conﬁrm whether apoAI lipidation involves a
conformation state similar to the intermediate state we de-
scribe for unfolding, and whether this state can be accurately
described as a molten globule.
In conclusion, several lines of evidence suggest that the
refolding of the protein goes through at least two interme-
diate states. 1), Comparing the ellipticity at 222 nm of the
unfolded protein in 5 M GdnHCl at equilibrium (Fig. 2 a,
solid line) to the ellipticity of the protein extrapolated to time
0 in the refolding experiment (Fig. 1 a, solid square), re-
vealed that the magnitude of the latter is signiﬁcantly larger
(ellipticity at 222 nm more negative). This suggests that a
signiﬁcant portion of the protein has already folded during
the ‘‘dead time’’ of the measurement (i.e., before the ﬁrst point
in the kinetic trace was collected). 2), The kinetics of the
refolding process as measured by protein ellipticity at 222 nm
is biphasic and can be best described by a double exponential
decay function. This further suggests that in addition to the
fast, burst phase intermediate (Iburst), which accumulates dur-
ing the dead time of the refolding experiment, there is a slow,
recovery intermediate (Irecovery) that appears later in the pro-
cess. 3), An overshoot of the CD signal was observed in the
ﬁrst phase of the folding process followed by a slower change
in the signal, which converged toward a value characteristic
of the native state of the protein. 4), At equilibrium, the transi-
tion curve for the ﬂuorescence peak intensity (Fig. 3 c) strongly
suggests that the unfolding process of the protein is going
through an equilibrium intermediate state (Iequil). One unre-
solved issue of this study is that we do not know if the fold-
ing intermediates observed in the kinetic studies are related
to the intermediate observed in the equilibrium experiments.
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